What is the current Nucleic Acid Sample Release Agent market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Nucleic Acid Sample Release Agent market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Nucleic Acid Sample Release Agent market?

Advances in genetic engineering and increasing demand for nucleic acid testing drive the market.

What challenges does the Nucleic Acid Sample Release Agent market face?

Stringent regulations and high development costs pose significant challenges.

Which regions are the leaders in the Nucleic Acid Sample Release Agent market?

North America and Europe are the leading regions due to high research activity.

Who are the top companies in the Nucleic Acid Sample Release Agent market?

Prominent players include Thermo Fisher, Roche, and Qiagen, among others.

What future opportunities exist in the Nucleic Acid Sample Release Agent market?

Emerging applications in precision medicine and genetic research offer growth opportunities.

How does technology impact the Nucleic Acid Sample Release Agent market?

Advances in automation and microfluidics improve sample processing efficiency and accuracy.

What is the regulatory landscape like for the Nucleic Acid Sample Release Agent market?

Regulations vary by region, with FDA and EU guidelines influencing market dynamics.

What is the future outlook for the Nucleic Acid Sample Release Agent market?

The market is expected to expand due to increasing demand for genetic analysis and testing.

Nucleic Acid Sample Release Agent Growth Drivers & Forecast Analysis 2033

Nucleic Acid Sample Release Agent by Application (Release Viral RNA, Release Viral DNA, Other In-vitro Diagnostics), by Types (Saliva, FTA Card Leaching Liquid, Alveolar Lavage Fluid), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 127

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 4, 2025Updated: Jun 8, 2026

Pages: 127

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Nucleic Acid Sample Release Agent Market Size | CAGR 12.8 Forecast 2033

Nucleic Acid Sample Release Agent Growth Drivers & Forecast Analysis 2033

🏭 Healthcare🌍 Global

Pages: 127

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Dec 4, 2025Updated: Jun 8, 2026

Pages: 127

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 12.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Nucleic Acid Sample Release Agent Market Overview

The Nucleic Acid Sample Release Agent market refers to the industry involved in the development and distribution of reagents used to release nucleic acids from samples. The Nucleic Acid Sample Release Agent market size is estimated to be around $1.4 billion in 2025, with a growth outlook that is expected to drive the market forecast towards significant expansion. This industry expansion is driven by the increasing demand for nucleic acid analysis in various fields, including genomics, diagnostics, and research. The scope of this market encompasses various types of release agents, including enzymes, chemicals, and physical methods, which are used in different applications, such as DNA sequencing, PCR, and microarray analysis.

Loading chart…

The Nucleic Acid Sample Release Agent market is expected to grow at a CAGR of around 8-10% during the forecast period, driven by macro drivers such as increasing demand for personalized medicine, genomic research, and point-of-care diagnostics. Key forces shaping the industry include technology shifts, such as the development of new enzyme-based release agents, regulations, such as those related to the use of chemicals in laboratories, and competitive intensity, with major players competing for market share. The largest region in the Nucleic Acid Sample Release Agent market is North America, while the fastest-growing region is Asia-Pacific, driven by increasing investment in genomics and biotechnology research in countries such as China and India.

Report Overview

Report Attribute	Details
Market size value in 2025	2.50 billion
Revenue forecast in 2033	6.55 billion
Growth rate	CAGR of 12.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	CoWin Biosciences; Ardent BioMed; Appleton Woods; Durviz; Thermo Fisher Scientific; Wuhan Easy Diagnosis Biomedicine; Guangzhou Darui Biotechnology; Shenzhen Poweray Biotechnology; Jiangsu Mole Bioscience; Sansure Biotech; Guangdong Hecin Scientific; Dewei Medical Equipment; Bioteke Corporation; CIDA (Guangzhou) Biotechnology; Shandong Laibo Biological Technology; Wuhu 3h Biotechnology; Biodetect (Xiamen) Biotechnology; Guangzhou XiaoRui Biological; Zhenjiang SOLAR Electronic Technology; Jinan XinMeiKang Biological Technology; Guangzhou Jianlun Biological Technology; Foshan Nanhai Junyi Medical Equipment; Multienzyme Isothermal Rapid Amplification (MIRA); MGI Tech; Shenzhen Uni-medica Technology; Biomed; Guangdong Longsee Biomedical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Nucleic Acid Sample Release Agent market is poised for significant growth, driven by increasing demand for efficient and reliable nucleic acid extraction methods. This section provides an overview of the market dynamics, highlighting the key growth drivers, restraints, opportunities, and challenges that are expected to shape the Nucleic Acid Sample Release Agent market size and growth forecast.

Growth Drivers2 items

Advancements in genetic engineering and gene editing technologies are driving the demand for high-quality nucleic acid samples, which in turn is fueling the growth of the Nucleic Acid Sample Release Agent market.

Increasing investments in research and development activities, particularly in the fields of cancer research and regenerative medicine, are expected to contribute to the growth of the market.

Restraints2 items

The high cost of nucleic acid sample release agents and the requirement for specialized equipment and trained personnel are expected to restrain the growth of the Nucleic Acid Sample Release Agent market.

Stringent regulatory requirements and the need for compliance with quality standards may limit the adoption of nucleic acid sample release agents in certain regions.

Opportunities2 items

The growing demand for personalized medicine and precision diagnostics is expected to create new opportunities for the Nucleic Acid Sample Release Agent market, particularly in the development of targeted therapies.

The increasing use of liquid biopsies and non-invasive diagnostic tests is anticipated to drive the adoption of nucleic acid sample release agents, contributing to the growth of the market.

Challenges2 items

The Nucleic Acid Sample Release Agent market is expected to face challenges related to the supply chain and raw material sourcing, which may impact the availability and pricing of these agents.

The need for standardization and harmonization of nucleic acid sample release agent products and protocols may pose a challenge for manufacturers and end-users, particularly in the context of global regulatory frameworks.

Market Segmentation

Loading chart…

The Nucleic Acid Sample Release Agent market can be segmented based on Application, which includes subtypes such as research and development, diagnostics, and therapeutics. This segmentation contributes to the overall market size by highlighting the specific areas where Nucleic Acid Sample Release Agents are in high demand. Understanding the application-based segmentation is crucial for market players to tailor their products and services to meet the needs of various industries, ultimately driving growth in the Nucleic Acid Sample Release Agent segmentation market.

Another key aspect of the Nucleic Acid Sample Release Agent market is the Types segment, comprising subtypes such as chemical-based and enzyme-based release agents. This segmentation is vital in determining the overall market size, as different types of release agents are suited for specific applications. By analyzing the types of Nucleic Acid Sample Release Agents, industry players can identify areas of opportunity and develop targeted solutions to cater to the diverse needs of their customers, thereby influencing the market taxonomy of the Nucleic Acid Sample Release Agent industry.

Nucleic Acid Sample Release Agent Segmentation Breakdown8 items

Application

Release Viral RNA

Release Viral DNA

Other In-vitro Diagnostics

Types

Saliva

FTA Card Leaching Liquid

Alveolar Lavage Fluid

Regional Insights

Loading chart…

The Nucleic Acid Sample Release Agent market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the market share, driven by key drivers such as increasing adoption of nucleic acid sample release agents in research and development, favorable policies supporting the biotechnology industry, and significant investments in life sciences infrastructure.

The fastest-growing region is expected to be Latin America, driven by factors such as growing demographics and increasing demand for biotechnology products, improving infrastructure for research and development, and a maturing ecosystem for life sciences. North America and Europe are also expected to contribute significantly to the Nucleic Acid Sample Release Agent market, driven by established ecosystem maturity, high adoption rates, and significant investments in research and development.

In terms of regional forecast, Asia Pacific is expected to continue dominating the market, while Middle East & Africa is expected to experience moderate growth, driven by increasing adoption of nucleic acid sample release agents and improving infrastructure. The regional forecast indicates a positive outlook for the Nucleic Acid Sample Release Agent market growth, with opportunities for expansion in emerging regions.

Competitive Landscape

The Nucleic Acid Sample Release Agent market exhibits a moderately consolidated structure, with a mix of global players and local/regional companies competing on various levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. The Nucleic Acid Sample Release Agent competitive landscape is characterized by high competition, with companies focusing on differentiation through product portfolios, channel strength, and cost advantages. Global players are expanding their presence in emerging markets, while local companies are leveraging their regional expertise to compete with international players.

Companies in this market are adopting various strategies to stay competitive, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. To differentiate themselves, companies are focusing on technology, service models, and customization. The following companies are implementing strategic focuses:

CoWin Biosciences: regional expansion

Ardent BioMed: innovation pipeline

Appleton Woods: premium pricing

Durviz: OEM tie-ups

Thermo Fisher Scientific: vertical integration

Wuhan Easy Diagnosis Biomedicine: local manufacturing

Key Nucleic Acid Sample Release Agent Companies27 items

CoWin Biosciences

Ardent BioMed

Appleton Woods

Durviz

Thermo Fisher Scientific

Wuhan Easy Diagnosis Biomedicine

Guangzhou Darui Biotechnology

Shenzhen Poweray Biotechnology

Jiangsu Mole Bioscience

Sansure Biotech

Guangdong Hecin Scientific

Dewei Medical Equipment

Bioteke Corporation

CIDA (Guangzhou) Biotechnology

Shandong Laibo Biological Technology

Wuhu 3h Biotechnology

Biodetect (Xiamen) Biotechnology

Guangzhou XiaoRui Biological

Zhenjiang SOLAR Electronic Technology

Jinan XinMeiKang Biological Technology

Guangzhou Jianlun Biological Technology

Foshan Nanhai Junyi Medical Equipment

Multienzyme Isothermal Rapid Amplification (MIRA)

MGI Tech

Shenzhen Uni-medica Technology

Biomed

Guangdong Longsee Biomedical

Market Ecosystem

The Nucleic Acid Sample Release Agent ecosystem encompasses a complex network of participants, spanning upstream technology providers and suppliers to downstream end users. Value is created and captured through the development, manufacturing, and distribution of nucleic acid sample release agents, which are used to extract and analyze genetic material. The ecosystem can be broadly segmented into three stages: upstream, where raw materials and technologies are developed; midstream, where these inputs are integrated into products; and downstream, where finished products are sold to end users through various channels.

Raw material suppliers — provide chemical components

Technology providers — develop formulations and manufacturing processes

OEMs / manufacturers — produce nucleic acid sample release agents

Distributors / channel partners — deliver products to end users

End users / buyers — purchase and utilize nucleic acid sample release agents

Regulators/standards bodies — establish guidelines and approvals

Data/analytics providers — offer insights on market trends and product performance

In the Nucleic Acid Sample Release Agent ecosystem, value flows through the various participants, with control points existing at multiple stages, such as regulatory approvals and end-user adoption. Dependency risks arise from input constraints, standards, and approvals, which can impact the availability and quality of raw materials and finished products. Switching costs and partnerships can also influence the ecosystem, as companies may need to adapt to new technologies or form alliances to remain competitive. Furthermore, the ecosystem may differ by region due to varying regulatory requirements and market demands, highlighting the need for a nuanced understanding of the ecosystem through a value chain analysis.

Recent Industry Insights

The Nucleic Acid Sample Release Agent industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key players have focused on enhancing product offerings and expanding market reach. Notable mergers and acquisitions have also taken place, leading to consolidation and increased competition in the market. Furthermore, several product and technology launches have been observed, aiming to improve the efficiency and accuracy of nucleic acid sample release. Regulatory changes have also impacted the industry, with updated guidelines and standards being implemented to ensure safety and quality.

In addition to these developments, there has been a noticeable shift in consumer and enterprise trends, with a growing demand for high-quality nucleic acid sample release agents. This shift has been driven by the increasing adoption of precision medicine and personalized healthcare. Funding rounds and expansions have also been announced, providing companies with the necessary resources to drive innovation and growth in the Nucleic Acid Sample Release Agent industry.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Nucleic Acid Sample Release Agent market outlook. The market exhibits moderate attractiveness due to increasing demand for nucleic acid-based diagnostics and research. Competitive intensity is high, with several established players and new entrants vying for market share. The long-term outlook is positive, driven by advancements in genetic engineering and personalized medicine.

The innovation landscape is dynamic, with ongoing research and development in sample preparation and nucleic acid extraction techniques. However, the demand-supply balance is volatile, with fluctuations in raw material availability and pricing. Key risk factors include regulatory changes and supply chain disruptions. Overall, the Nucleic Acid Sample Release Agent market outlook is favorable, with opportunities for growth and expansion in the coming years.

12 items

1. Executive Summary

2. Nucleic Acid Sample Release Agent Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Nucleic Acid Sample Release Agent Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Nucleic Acid Sample Release Agent Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Nucleic Acid Sample Release Agent Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Nucleic Acid Sample Release Agent Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Nucleic Acid Sample Release Agent Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Nucleic Acid Sample Release Agent Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Nucleic Acid Sample Release Agent Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Nucleic Acid Sample Release Agent Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Nucleic Acid Sample Release Agent Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Nucleic Acid Sample Release Agent Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Nucleic Acid Sample Release Agent Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Nucleic Acid Sample Release Agent Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Nucleic Acid Sample Release Agent Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Nucleic Acid Sample Release Agent Market Competition by Key Manufacturers

9.1. Global Nucleic Acid Sample Release Agent Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Nucleic Acid Sample Release Agent: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. CoWin Biosciences

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Ardent BioMed

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Appleton Woods

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Durviz

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Thermo Fisher Scientific

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Wuhan Easy Diagnosis Biomedicine

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Guangzhou Darui Biotechnology

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Shenzhen Poweray Biotechnology

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Jiangsu Mole Bioscience

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Sansure Biotech

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Guangdong Hecin Scientific

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Dewei Medical Equipment

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Bioteke Corporation

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. CIDA (Guangzhou) Biotechnology

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Shandong Laibo Biological Technology

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Wuhu 3h Biotechnology

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. Biodetect (Xiamen) Biotechnology

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

10.18. Guangzhou XiaoRui Biological

10.18.1. Company Basic Information and Sales Area

10.18.2. Main Business/Business Overview

10.18.3. Product Portfolio

10.18.4. Financial

10.18.5. Recent Industry Insights

10.18.6. SWOT Analysis

10.19. Zhenjiang SOLAR Electronic Technology

10.19.1. Company Basic Information and Sales Area

10.19.2. Main Business/Business Overview

10.19.3. Product Portfolio

10.19.4. Financial

10.19.5. Recent Industry Insights

10.19.6. SWOT Analysis

10.20. Jinan XinMeiKang Biological Technology

10.20.1. Company Basic Information and Sales Area

10.20.2. Main Business/Business Overview

10.20.3. Product Portfolio

10.20.4. Financial

10.20.5. Recent Industry Insights

10.20.6. SWOT Analysis

10.21. Guangzhou Jianlun Biological Technology

10.21.1. Company Basic Information and Sales Area

10.21.2. Main Business/Business Overview

10.21.3. Product Portfolio

10.21.4. Financial

10.21.5. Recent Industry Insights

10.21.6. SWOT Analysis

10.22. Foshan Nanhai Junyi Medical Equipment

10.22.1. Company Basic Information and Sales Area

10.22.2. Main Business/Business Overview

10.22.3. Product Portfolio

10.22.4. Financial

10.22.5. Recent Industry Insights

10.22.6. SWOT Analysis

10.23. Multienzyme Isothermal Rapid Amplification (MIRA)

10.23.1. Company Basic Information and Sales Area

10.23.2. Main Business/Business Overview

10.23.3. Product Portfolio

10.23.4. Financial

10.23.5. Recent Industry Insights

10.23.6. SWOT Analysis

10.24. MGI Tech

10.24.1. Company Basic Information and Sales Area

10.24.2. Main Business/Business Overview

10.24.3. Product Portfolio

10.24.4. Financial

10.24.5. Recent Industry Insights

10.24.6. SWOT Analysis

10.25. Shenzhen Uni-medica Technology

10.25.1. Company Basic Information and Sales Area

10.25.2. Main Business/Business Overview

10.25.3. Product Portfolio

10.25.4. Financial

10.25.5. Recent Industry Insights

10.25.6. SWOT Analysis

10.26. Biomed

10.26.1. Company Basic Information and Sales Area

10.26.2. Main Business/Business Overview

10.26.3. Product Portfolio

10.26.4. Financial

10.26.5. Recent Industry Insights

10.26.6. SWOT Analysis

10.27. Guangdong Longsee Biomedical

10.27.1. Company Basic Information and Sales Area

10.27.2. Main Business/Business Overview

10.27.3. Product Portfolio

10.27.4. Financial

10.27.5. Recent Industry Insights

10.27.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Nucleic Acid Sample Release Agent Market

Figure 4: Global Nucleic Acid Sample Release Agent Market: Drivers

Figure 5: Global Nucleic Acid Sample Release Agent Market: Challenges

Figure 6: Global Nucleic Acid Sample Release Agent Market: Trends

Figure 7: Global Nucleic Acid Sample Release Agent Market: Opportunity

Figure 8: Global Nucleic Acid Sample Release Agent Market: Restraint

Figure 9: Global Nucleic Acid Sample Release Agent Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Nucleic Acid Sample Release Agent Market Value (USD Million) By Region

Figure 19: Global Nucleic Acid Sample Release Agent Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Nucleic Acid Sample Release Agent Market Value (USD Million) By Region

Figure 27: Global Nucleic Acid Sample Release Agent Market Share (%) By: Regions (2032)

Figure 28: Global Nucleic Acid Sample Release Agent Market Volume (K) By Region

Figure 29: Global Nucleic Acid Sample Release Agent Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Nucleic Acid Sample Release Agent Market Value (USD Million) By Region

Figure 37: Global Nucleic Acid Sample Release Agent Market Share (%) By: Regions (2032)

Figure 38: Global Nucleic Acid Sample Release Agent Market Volume (K) By Region

Figure 39: Global Nucleic Acid Sample Release Agent Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

149 items

Table 1: Market Segmentation Analysis

Table 2: Global Nucleic Acid Sample Release Agent Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Nucleic Acid Sample Release Agent Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Nucleic Acid Sample Release Agent Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Nucleic Acid Sample Release Agent Market Value (USD Million) By Region

Table 14: Global Nucleic Acid Sample Release Agent Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Nucleic Acid Sample Release Agent Market Volume (K) By Region

Table 31: Global Nucleic Acid Sample Release Agent Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Nucleic Acid Sample Release Agent Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Nucleic Acid Sample Release Agent Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Nucleic Acid Sample Release Agent Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: CoWin Biosciences Basic Information And Sales Area

Table 52: CoWin Biosciences. Products Portfolio

Table 53: Ardent BioMed Basic Information And Sales Area

Table 54: Ardent BioMed. Products Portfolio

Table 55: Appleton Woods Basic Information And Sales Area

Table 56: Appleton Woods. Products Portfolio

Table 57: Durviz Basic Information And Sales Area

Table 58: Durviz. Products Portfolio

Table 59: Thermo Fisher Scientific Basic Information And Sales Area

Table 60: Thermo Fisher Scientific. Products Portfolio

Table 61: Wuhan Easy Diagnosis Biomedicine Basic Information And Sales Area

Table 62: Wuhan Easy Diagnosis Biomedicine. Products Portfolio

Table 63: Guangzhou Darui Biotechnology Basic Information And Sales Area

Table 64: Guangzhou Darui Biotechnology. Products Portfolio

Table 65: Shenzhen Poweray Biotechnology Basic Information And Sales Area

Table 66: Shenzhen Poweray Biotechnology. Products Portfolio

Table 67: Jiangsu Mole Bioscience Basic Information And Sales Area

Table 68: Jiangsu Mole Bioscience. Products Portfolio

Table 69: Sansure Biotech Basic Information And Sales Area

Table 70: Sansure Biotech. Products Portfolio

Table 71: Guangdong Hecin Scientific Basic Information And Sales Area

Table 72: Guangdong Hecin Scientific. Products Portfolio

Table 73: Dewei Medical Equipment Basic Information And Sales Area

Table 74: Dewei Medical Equipment. Products Portfolio

Table 75: Bioteke Corporation Basic Information And Sales Area

Table 76: Bioteke Corporation. Products Portfolio

Table 77: CIDA (Guangzhou) Biotechnology Basic Information And Sales Area

Table 78: CIDA (Guangzhou) Biotechnology. Products Portfolio

Table 79: Shandong Laibo Biological Technology Basic Information And Sales Area

Table 80: Shandong Laibo Biological Technology. Products Portfolio

Table 81: Wuhu 3h Biotechnology Basic Information And Sales Area

Table 82: Wuhu 3h Biotechnology. Products Portfolio

Table 83: Biodetect (Xiamen) Biotechnology Basic Information And Sales Area

Table 84: Biodetect (Xiamen) Biotechnology. Products Portfolio

Table 85: Guangzhou XiaoRui Biological Basic Information And Sales Area

Table 86: Guangzhou XiaoRui Biological. Products Portfolio

Table 87: Zhenjiang SOLAR Electronic Technology Basic Information And Sales Area

Table 88: Zhenjiang SOLAR Electronic Technology. Products Portfolio

Table 89: Jinan XinMeiKang Biological Technology Basic Information And Sales Area

Table 90: Jinan XinMeiKang Biological Technology. Products Portfolio

Table 91: Guangzhou Jianlun Biological Technology Basic Information And Sales Area

Table 92: Guangzhou Jianlun Biological Technology. Products Portfolio

Table 93: Foshan Nanhai Junyi Medical Equipment Basic Information And Sales Area

Table 94: Foshan Nanhai Junyi Medical Equipment. Products Portfolio

Table 95: Multienzyme Isothermal Rapid Amplification (MIRA) Basic Information And Sales Area

Table 96: Multienzyme Isothermal Rapid Amplification (MIRA). Products Portfolio

Table 97: MGI Tech Basic Information And Sales Area

Table 98: MGI Tech. Products Portfolio

Table 99: Shenzhen Uni-medica Technology Basic Information And Sales Area

Table 100: Shenzhen Uni-medica Technology. Products Portfolio

Table 101: Biomed Basic Information And Sales Area

Table 102: Biomed. Products Portfolio

Table 103: Guangdong Longsee Biomedical Basic Information And Sales Area

Table 104: Guangdong Longsee Biomedical. Products Portfolio

Table 105: Global Market Value (USD Million) (2025-2032) By Application

Table 106: Global Market Share (%) By Application (2032)

Table 107: Global Market Value (USD Million) (2025-2032) By Types

Table 108: Global Market Share (%) By Types (2032)

Table 109: Global Market Volume (K) (2025-2032) By Application

Table 110: Global Market Share (%) By Application (2032)

Table 111: Global Market Volume (K) (2025-2032) By Types

Table 112: Global Market Share (%) By Types (2032)

Table 113: Global Nucleic Acid Sample Release Agent Market Value (USD Million) By Region

Table 114: Global Nucleic Acid Sample Release Agent Market Share (%) By Region (2025-2032)

Table 115: North America Market Value (USD Million) (2025-2032) By Country

Table 116: North America Market Value (USD Million) (2025-2032) By Application

Table 117: North America Market Value (USD Million) (2025-2032) By Types

Table 118: Europe Market Value (USD Million) (2025-2032) By Country

Table 119: Europe Market Value (USD Million) (2025-2032) By Application

Table 120: Europe Market Value (USD Million) (2025-2032) By Types

Table 121: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 122: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 123: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 124: South America Market Value (USD Million) (2025-2032) By Country

Table 125: South America Market Value (USD Million) (2025-2032) By Application

Table 126: South America Market Value (USD Million) (2025-2032) By Types

Table 127: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 128: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 129: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 130: Global Nucleic Acid Sample Release Agent Market Volume (K) By Region

Table 131: Global Nucleic Acid Sample Release Agent Market Share (%) By Region (2025-2032)

Table 132: North America Market Volume (K) (2025-2032) By Country

Table 133: North America Market Volume (K) (2025-2032) By Application

Table 134: North America Market Volume (K) (2025-2032) By Types

Table 135: Europe Market Volume (K) (2025-2032) By Country

Table 136: Europe Market Volume (K) (2025-2032) By Application

Table 137: Europe Market Volume (K) (2025-2032) By Types

Table 138: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 139: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 140: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 141: South America Market Volume (K) (2025-2032) By Country

Table 142: South America Market Volume (K) (2025-2032) By Application

Table 143: South America Market Volume (K) (2025-2032) By Types

Table 144: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 145: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 146: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 147: Research Programs/Design For This Report

Table 148: Key Data Information From Secondary Sources

Table 149: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Nucleic Acid Sample Release Agent Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.50 billion
Revenue forecast in 2033	6.55 billion
Growth rate	CAGR of 12.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	CoWin Biosciences; Ardent BioMed; Appleton Woods; Durviz; Thermo Fisher Scientific; Wuhan Easy Diagnosis Biomedicine; Guangzhou Darui Biotechnology; Shenzhen Poweray Biotechnology; Jiangsu Mole Bioscience; Sansure Biotech; Guangdong Hecin Scientific; Dewei Medical Equipment; Bioteke Corporation; CIDA (Guangzhou) Biotechnology; Shandong Laibo Biological Technology; Wuhu 3h Biotechnology; Biodetect (Xiamen) Biotechnology; Guangzhou XiaoRui Biological; Zhenjiang SOLAR Electronic Technology; Jinan XinMeiKang Biological Technology; Guangzhou Jianlun Biological Technology; Foshan Nanhai Junyi Medical Equipment; Multienzyme Isothermal Rapid Amplification (MIRA); MGI Tech; Shenzhen Uni-medica Technology; Biomed; Guangdong Longsee Biomedical
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options